Skip to main content
Livermore
Livermore
ZHEN

Fred Alger Management, LLC

SEC CIK
0000003520
Latest filing
Aug 14, 2026

RARE holding history

Ultragenyx Pharmaceutical Inc. in every 13F filed by Fred Alger Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RARE overviewAll 13F holders of RAREFull Q2 2026 holdings

Shares (Q2 2026)
143,155
Value
$4.78M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RARE by Fred Alger Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026143,155$4.78M<0.1%−154,877−52.0%ReducedHolders
Q1 2026298,032$6.24M<0.1%−113,831−27.6%ReducedHolders
Q4 2025411,863$9.47M<0.1%−36,854−8.2%ReducedHolders
Q3 2025448,717$13.5M0.1%+18,378+4.3%AddedHolders
Q2 2025430,339$15.6M0.1%−94,298−18.0%ReducedHolders
Q1 2025524,637$19.0M0.1%+58,372+12.5%AddedHolders
Q4 2024466,265$19.6M0.1%−70,033−13.1%ReducedHolders
Q3 2024536,298$29.8M0.1%−12,607−2.3%ReducedHolders
Q2 2024548,905$22.6M0.1%−32,646−5.6%ReducedHolders
Q1 2024581,551$27.2M0.1%−22,425−3.7%ReducedHolders
Q4 2023603,976$28.9M0.2%−34,890−5.5%ReducedHolders
Q3 2023638,866$22.8M0.1%−17,239−2.6%ReducedHolders
Q2 2023656,105$30.3M0.2%+112,553+20.7%AddedHolders
Q1 2023543,552$21.8M0.1%+48,012+9.7%AddedHolders
Q4 2022495,540$23.0M0.1%+129,827+35.5%AddedHolders
Q3 2022365,713$15.1M0.1%+103,512+39.5%AddedHolders
Q2 2022262,201$15.6M0.1%−17,572−6.3%ReducedHolders
Q1 2022279,773$20.3M0.1%−13,727−4.7%ReducedHolders
Q4 2021293,500$24.7M0.1%+2,577+0.9%AddedHolders
Q3 2021290,923$26.2M0.1%+99,491+52.0%AddedHolders
Q2 2021191,432$18.3M<0.1%+16,868+9.7%AddedHolders
Q1 2021174,564$19.9M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.